Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews

被引：0
|
作者：
Sharea Ijaz
Blanca Bolea
Simon Davies
Jelena Savović
Alison Richards
Sarah Sullivan
Paul Moran
机构：
[1] University of Bristol,Bristol Medical School
[2] National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) West,Centre for Addiction and Mental Health (CAMH)
[3] University of Toronto,undefined
来源：
BMC Psychiatry | / 18卷
关键词：
Schizophrenia; Antipsychotics; Diabetes mellitus; Metabolic syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
    Ijaz, Sharea
    Bolea, Blanca
    Davies, Simon
    Savovic, Jelena
    Richards, Alison
    Sullivan, Sarah
    Moran, Paul
    BMC PSYCHIATRY, 2018, 18
  • [2] Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
    Jeon, Sang Won
    Kim, Yong-Ku
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [3] Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders
    Aziz, Karim Abdel
    Ahmed, Hind Mohd
    Stip, Emmanuel
    El-Gabry, Dina Aly
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, 39 (04) : 257 - 266
  • [4] Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia An Egyptian Study
    El-Gabry, Dina M. Aly
    Aziz, Karim Abdel
    Okasha, Tarek
    Azzam, Hanan
    Okasha, Ahmed
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (01) : 27 - 33
  • [5] Critical review of antipsychotic polypharmacy in the treatment of schizophrenia
    Fleischhacker, W. Wolfgang
    Uchida, Hiroyuki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (07): : 1083 - 1093
  • [6] Antipsychotic polypharmacy in schizophrenia: results from a systematic review and meta-analysis of augmentation with a second antipsychotic
    Galling, B.
    Roldan, A.
    Correll, C. U.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S499 - S499
  • [7] Antipsychotic polypharmacy and high-dose antipsychotic therapy compared to antipsychotic monotherapy at standard doses in schizophrenia - a systematic review
    Lawrence, Christopher
    Roberts, Chloe
    Galides, Chloe
    Chamberlain, Samuel R.
    Hou, Ruihua
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025, 39 (02) : 132 - 140
  • [8] Antipsychotic Polypharmacy Among Patients With Schizophrenia in Africa: A Systematic Review and Meta-Analysis
    Ayenew, Wondim
    Asmamaw, Getahun
    Bitew, Teshome
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (12): : 956 - 964
  • [9] Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis
    Matsui, Kentaro
    Tokumasu, Takahiro
    Takekita, Yoshiteru
    Inada, Ken
    Kanazawa, Tetsufumi
    Kishimoto, Taishiro
    Takasu, Shotaro
    Tani, Hideaki
    Tarutani, Seiichiro
    Hashimoto, Naoki
    Yamada, Hiroki
    Yamanouchi, Yoshio
    Takeuchi, Hiroyoshi
    SCHIZOPHRENIA RESEARCH, 2019, 209 : 50 - 57
  • [10] Interventions to reduce antipsychotic polypharmacy: A systematic review
    Tani, Hideaki
    Uchida, Hiroyuki
    Suzuki, Takefumi
    Fujii, Yasuo
    Mimura, Masaru
    SCHIZOPHRENIA RESEARCH, 2013, 143 (01) : 215 - 220
12345